These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 14520944

  • 1. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE, Murav'ev IuV, Radenska-Lopovok SG, Nasonova VA.
    Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
    Karateev AE, Nasonov EL, Radenska-Lopovok SG.
    Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
    [Abstract] [Full Text] [Related]

  • 3. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA.
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [Abstract] [Full Text] [Related]

  • 4. [Age and eradication treatment of duodenal ulcer].
    Minushkin ON, Volodin DV, Zverkov IV, Ivanova OI, Shuleshova AG, Burdina EG.
    Ter Arkh; 2007 Oct; 79(2):22-6. PubMed ID: 17460963
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Oct; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 6. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
    Karameev AE.
    Ter Arkh; 2003 Oct; 75(5):74-8. PubMed ID: 12847904
    [Abstract] [Full Text] [Related]

  • 7. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE, Nasonova VA.
    Ter Arkh; 2008 Oct; 80(5):62-6. PubMed ID: 18590118
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 9. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A, Ozdogan O, Celikel CA, Tozun N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [Abstract] [Full Text] [Related]

  • 10. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 11. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R, Pinto Valdivia JL, Ramírez D, Cok García J, Bussalleu Rivera A.
    Rev Gastroenterol Peru; 2005 Oct; 25(1):23-41. PubMed ID: 15818420
    [Abstract] [Full Text] [Related]

  • 12. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
    Schaeverbeke T, Broutet N, Zerbib F, Combe B, Bertin P, Lamouliatte H, Perié F, Joubert-Collin M, Mégraud F.
    Am J Gastroenterol; 2005 Dec; 100(12):2637-43. PubMed ID: 16393213
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT, Steen KS, Bloemena E, Lems WF, Kuipers EJ, Van de Laar MA, Bijlsma JW, Janssen M, Houben HH, Kostense PJ, Boers M, Dijkmans BA.
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [Abstract] [Full Text] [Related]

  • 14. [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
    Karateev AE, Murav'ev IuV.
    Klin Med (Mosk); 2001 Feb; 79(5):48-50. PubMed ID: 11510188
    [Abstract] [Full Text] [Related]

  • 15. [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate].
    Karateev AE, Uspenskiĭ IuP, Pakhomova IG, Nasonov EL.
    Ter Arkh; 2009 Feb; 81(6):62-7. PubMed ID: 19663196
    [Abstract] [Full Text] [Related]

  • 16. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC, Lu SN, Changchien CS.
    Hepatogastroenterology; 2003 Feb; 50(53):1731-4. PubMed ID: 14571829
    [Abstract] [Full Text] [Related]

  • 17. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
    Tan HJ, Rizal AM, Rosmadi MY, Goh KL.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
    [Abstract] [Full Text] [Related]

  • 18. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T, Konturek PC, Sliwowski Z, Kwiecień S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
    Butorov IV, Osoianu IuP, Butorov SI, Maksimov VV.
    Klin Med (Mosk); 2005 Sep; 83(12):50-3. PubMed ID: 16502725
    [Abstract] [Full Text] [Related]

  • 20. [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs].
    Maev IV, V'iuchnova ES, Staseva IV.
    Ter Arkh; 2004 Sep; 76(2):27-30. PubMed ID: 15106410
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.